The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HIV-1 Testing Market Research Report 2025
Synopsis
HIV tests are very accurate, but no test can detect the virus immediately after infection. How soon a test can detect HIV depends upon different factors, including the type of test being used. There are three types of HIV diagnostic tests: nucleic acid tests (NAT), antigen/antibody tests, and antibody tests.
The global HIV-1 Testing market was valued at US$ 4132 million in 2023 and is anticipated to reach US$ 7920.9 million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.
The HIV-1 Testing market is primarily driven by the ongoing efforts to combat the global HIV epidemic and the need for accurate and accessible diagnostic tools. HIV-1 testing plays a crucial role in early detection, treatment initiation, and prevention of HIV transmission. The growing awareness of the importance of early diagnosis, coupled with the expansion of HIV testing initiatives and public health campaigns, contributes to market growth. Moreover, advancements in testing technologies, such as rapid point-of-care tests and nucleic acid-based assays, further propel adoption. However, challenges include addressing stigma associated with HIV testing and ensuring equitable access to testing in underserved regions. Navigating quality assurance, providing counseling services, and keeping up with evolving viral strains are ongoing concerns. The market's success relies on continuous innovation in testing methods, collaborations between diagnostic manufacturers and healthcare providers, and comprehensive education on the benefits of HIV-1 testing while addressing the evolving challenges associated with HIV prevention, diagnosis, and treatment.
This report aims to provide a comprehensive presentation of the global market for HIV-1 Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV-1 Testing.
Report Scope
The HIV-1 Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV-1 Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV-1 Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Bio-Rad Laboratories
National Genetics Institute
Roche
Grifols Diagnostics
bioMerieux
CSL
Hologic
Takeda
Segment by Type
Antibody
Nucleic Acid Testing
Antigen
Segment by Application
Hospital
Independent Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV-1 Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HIV tests are very accurate, but no test can detect the virus immediately after infection. How soon a test can detect HIV depends upon different factors, including the type of test being used. There are three types of HIV diagnostic tests: nucleic acid tests (NAT), antigen/antibody tests, and antibody tests.
The global HIV-1 Testing market was valued at US$ 4132 million in 2023 and is anticipated to reach US$ 7920.9 million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.
The HIV-1 Testing market is primarily driven by the ongoing efforts to combat the global HIV epidemic and the need for accurate and accessible diagnostic tools. HIV-1 testing plays a crucial role in early detection, treatment initiation, and prevention of HIV transmission. The growing awareness of the importance of early diagnosis, coupled with the expansion of HIV testing initiatives and public health campaigns, contributes to market growth. Moreover, advancements in testing technologies, such as rapid point-of-care tests and nucleic acid-based assays, further propel adoption. However, challenges include addressing stigma associated with HIV testing and ensuring equitable access to testing in underserved regions. Navigating quality assurance, providing counseling services, and keeping up with evolving viral strains are ongoing concerns. The market's success relies on continuous innovation in testing methods, collaborations between diagnostic manufacturers and healthcare providers, and comprehensive education on the benefits of HIV-1 testing while addressing the evolving challenges associated with HIV prevention, diagnosis, and treatment.
This report aims to provide a comprehensive presentation of the global market for HIV-1 Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV-1 Testing.
Report Scope
The HIV-1 Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV-1 Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV-1 Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Bio-Rad Laboratories
National Genetics Institute
Roche
Grifols Diagnostics
bioMerieux
CSL
Hologic
Takeda
Segment by Type
Antibody
Nucleic Acid Testing
Antigen
Segment by Application
Hospital
Independent Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV-1 Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV-1 Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody
1.2.3 Nucleic Acid Testing
1.2.4 Antigen
1.3 Market by Application
1.3.1 Global HIV-1 Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Independent Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV-1 Testing Market Perspective (2019-2030)
2.2 HIV-1 Testing Growth Trends by Region
2.2.1 Global HIV-1 Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HIV-1 Testing Historic Market Size by Region (2019-2024)
2.2.3 HIV-1 Testing Forecasted Market Size by Region (2025-2030)
2.3 HIV-1 Testing Market Dynamics
2.3.1 HIV-1 Testing Industry Trends
2.3.2 HIV-1 Testing Market Drivers
2.3.3 HIV-1 Testing Market Challenges
2.3.4 HIV-1 Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV-1 Testing Players by Revenue
3.1.1 Global Top HIV-1 Testing Players by Revenue (2019-2024)
3.1.2 Global HIV-1 Testing Revenue Market Share by Players (2019-2024)
3.2 Global HIV-1 Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV-1 Testing Revenue
3.4 Global HIV-1 Testing Market Concentration Ratio
3.4.1 Global HIV-1 Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV-1 Testing Revenue in 2023
3.5 HIV-1 Testing Key Players Head office and Area Served
3.6 Key Players HIV-1 Testing Product Solution and Service
3.7 Date of Enter into HIV-1 Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV-1 Testing Breakdown Data by Type
4.1 Global HIV-1 Testing Historic Market Size by Type (2019-2024)
4.2 Global HIV-1 Testing Forecasted Market Size by Type (2025-2030)
5 HIV-1 Testing Breakdown Data by Application
5.1 Global HIV-1 Testing Historic Market Size by Application (2019-2024)
5.2 Global HIV-1 Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HIV-1 Testing Market Size (2019-2030)
6.2 North America HIV-1 Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HIV-1 Testing Market Size by Country (2019-2024)
6.4 North America HIV-1 Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV-1 Testing Market Size (2019-2030)
7.2 Europe HIV-1 Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HIV-1 Testing Market Size by Country (2019-2024)
7.4 Europe HIV-1 Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV-1 Testing Market Size (2019-2030)
8.2 Asia-Pacific HIV-1 Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HIV-1 Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific HIV-1 Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV-1 Testing Market Size (2019-2030)
9.2 Latin America HIV-1 Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HIV-1 Testing Market Size by Country (2019-2024)
9.4 Latin America HIV-1 Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV-1 Testing Market Size (2019-2030)
10.2 Middle East & Africa HIV-1 Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HIV-1 Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa HIV-1 Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott HIV-1 Testing Introduction
11.1.4 Abbott Revenue in HIV-1 Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories HIV-1 Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in HIV-1 Testing Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 National Genetics Institute
11.3.1 National Genetics Institute Company Detail
11.3.2 National Genetics Institute Business Overview
11.3.3 National Genetics Institute HIV-1 Testing Introduction
11.3.4 National Genetics Institute Revenue in HIV-1 Testing Business (2019-2024)
11.3.5 National Genetics Institute Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche HIV-1 Testing Introduction
11.4.4 Roche Revenue in HIV-1 Testing Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Grifols Diagnostics
11.5.1 Grifols Diagnostics Company Detail
11.5.2 Grifols Diagnostics Business Overview
11.5.3 Grifols Diagnostics HIV-1 Testing Introduction
11.5.4 Grifols Diagnostics Revenue in HIV-1 Testing Business (2019-2024)
11.5.5 Grifols Diagnostics Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Detail
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux HIV-1 Testing Introduction
11.6.4 bioMerieux Revenue in HIV-1 Testing Business (2019-2024)
11.6.5 bioMerieux Recent Development
11.7 CSL
11.7.1 CSL Company Detail
11.7.2 CSL Business Overview
11.7.3 CSL HIV-1 Testing Introduction
11.7.4 CSL Revenue in HIV-1 Testing Business (2019-2024)
11.7.5 CSL Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic HIV-1 Testing Introduction
11.8.4 Hologic Revenue in HIV-1 Testing Business (2019-2024)
11.8.5 Hologic Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda HIV-1 Testing Introduction
11.9.4 Takeda Revenue in HIV-1 Testing Business (2019-2024)
11.9.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global HIV-1 Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibody
Table 3. Key Players of Nucleic Acid Testing
Table 4. Key Players of Antigen
Table 5. Global HIV-1 Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global HIV-1 Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global HIV-1 Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global HIV-1 Testing Market Share by Region (2019-2024)
Table 9. Global HIV-1 Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global HIV-1 Testing Market Share by Region (2025-2030)
Table 11. HIV-1 Testing Market Trends
Table 12. HIV-1 Testing Market Drivers
Table 13. HIV-1 Testing Market Challenges
Table 14. HIV-1 Testing Market Restraints
Table 15. Global HIV-1 Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global HIV-1 Testing Market Share by Players (2019-2024)
Table 17. Global Top HIV-1 Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-1 Testing as of 2023)
Table 18. Ranking of Global Top HIV-1 Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by HIV-1 Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players HIV-1 Testing Product Solution and Service
Table 22. Date of Enter into HIV-1 Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HIV-1 Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global HIV-1 Testing Revenue Market Share by Type (2019-2024)
Table 26. Global HIV-1 Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global HIV-1 Testing Revenue Market Share by Type (2025-2030)
Table 28. Global HIV-1 Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global HIV-1 Testing Revenue Market Share by Application (2019-2024)
Table 30. Global HIV-1 Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global HIV-1 Testing Revenue Market Share by Application (2025-2030)
Table 32. North America HIV-1 Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America HIV-1 Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America HIV-1 Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe HIV-1 Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe HIV-1 Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe HIV-1 Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific HIV-1 Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific HIV-1 Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific HIV-1 Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America HIV-1 Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America HIV-1 Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America HIV-1 Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa HIV-1 Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa HIV-1 Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa HIV-1 Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott HIV-1 Testing Product
Table 50. Abbott Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Bio-Rad Laboratories Company Detail
Table 53. Bio-Rad Laboratories Business Overview
Table 54. Bio-Rad Laboratories HIV-1 Testing Product
Table 55. Bio-Rad Laboratories Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 56. Bio-Rad Laboratories Recent Development
Table 57. National Genetics Institute Company Detail
Table 58. National Genetics Institute Business Overview
Table 59. National Genetics Institute HIV-1 Testing Product
Table 60. National Genetics Institute Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 61. National Genetics Institute Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche HIV-1 Testing Product
Table 65. Roche Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Grifols Diagnostics Company Detail
Table 68. Grifols Diagnostics Business Overview
Table 69. Grifols Diagnostics HIV-1 Testing Product
Table 70. Grifols Diagnostics Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 71. Grifols Diagnostics Recent Development
Table 72. bioMerieux Company Detail
Table 73. bioMerieux Business Overview
Table 74. bioMerieux HIV-1 Testing Product
Table 75. bioMerieux Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 76. bioMerieux Recent Development
Table 77. CSL Company Detail
Table 78. CSL Business Overview
Table 79. CSL HIV-1 Testing Product
Table 80. CSL Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 81. CSL Recent Development
Table 82. Hologic Company Detail
Table 83. Hologic Business Overview
Table 84. Hologic HIV-1 Testing Product
Table 85. Hologic Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 86. Hologic Recent Development
Table 87. Takeda Company Detail
Table 88. Takeda Business Overview
Table 89. Takeda HIV-1 Testing Product
Table 90. Takeda Revenue in HIV-1 Testing Business (2019-2024) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV-1 Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global HIV-1 Testing Market Share by Type: 2023 VS 2030
Figure 3. Antibody Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Antigen Features
Figure 6. Global HIV-1 Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global HIV-1 Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Independent Laboratory Case Studies
Figure 10. Other Case Studies
Figure 11. HIV-1 Testing Report Years Considered
Figure 12. Global HIV-1 Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global HIV-1 Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global HIV-1 Testing Market Share by Region: 2023 VS 2030
Figure 15. Global HIV-1 Testing Market Share by Players in 2023
Figure 16. Global Top HIV-1 Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-1 Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by HIV-1 Testing Revenue in 2023
Figure 18. North America HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America HIV-1 Testing Market Share by Country (2019-2030)
Figure 20. United States HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe HIV-1 Testing Market Share by Country (2019-2030)
Figure 24. Germany HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific HIV-1 Testing Market Share by Region (2019-2030)
Figure 32. China HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America HIV-1 Testing Market Share by Country (2019-2030)
Figure 40. Mexico HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa HIV-1 Testing Market Share by Country (2019-2030)
Figure 44. Turkey HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia HIV-1 Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 48. National Genetics Institute Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 50. Grifols Diagnostics Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 51. bioMerieux Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 52. CSL Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 53. Hologic Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 54. Takeda Revenue Growth Rate in HIV-1 Testing Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
